Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 113,009 | 253,256 | 162,855 | 274,305 | 228,705 |
| Marketable Securities | 58,742 | 140,915 | 136,593 | 304,781 | 237,626 |
| Receivables | 94,163 | 75,347 | 91,460 | 92,375 | 86,106 |
| Inventories | 31,553 | 26,691 | 34,443 | 37,258 | 40,645 |
| Other current assets | 0 | 10,000 | 45,508 | 0 | 0 |
| TOTAL | $316,567 | $525,170 | $481,868 | $718,558 | $606,674 |
| Non-Current Assets | |||||
| PPE Net | 4,116 | 7,521 | 7,904 | 24,460 | 28,725 |
| Intangibles | 446,133 | 639,546 | 797,992 | 1,731,662 | 1,835,959 |
| Other Non-Current Assets | 24,411 | 3,222 | 612,592 | 3,746 | 4,852 |
| TOTAL | $474,660 | $650,289 | $1,418,488 | $1,759,868 | $1,869,536 |
| Total Assets | $791,227 | $1,175,459 | $1,900,356 | $2,478,426 | $2,476,210 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 21,166 | 17,500 |
| Accounts payable and accrued liabilities | 27,021 | 14,487 | 7,717 | 3,684 | 4,906 |
| Accrued Expenses | 177,079 | 129,537 | 166,732 | 156,008 | 106,363 |
| Other current liabilities | 17 | 144 | 103,269 | 97,068 | 96,967 |
| TOTAL | $208,194 | $165,444 | $277,718 | $312,877 | $245,921 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 466,291 | 785,992 | 803,669 |
| Deferred Revenues | N/A | N/A | N/A | 34,951 | 20,185 |
| Other Non-Current Liabilities | 296,914 | 263,360 | 366,103 | 233,252 | 300,118 |
| TOTAL | $296,914 | $263,360 | $832,394 | $1,231,160 | $1,298,025 |
| Total Liabilities | $505,108 | $428,804 | $1,110,112 | $1,544,037 | $1,543,946 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,266 | 34,713 | 34,089 | 34,339 | 34,749 |
| Common Shares | 339 | 346 | 341 | 343 | 347 |
| Retained earnings | -1,008,898 | -542,442 | -477,817 | -300,147 | -297,664 |
| Other shareholders' equity | -3,239 | -3,985 | -3,908 | -3,838 | -4,205 |
| TOTAL | $286,119 | $746,655 | $790,244 | $934,389 | $932,264 |
| Total Liabilities And Equity | $791,227 | $1,175,459 | $1,900,356 | $2,478,426 | $2,476,210 |